After completing his undergraduate studies in Bioscience and Technology and Pre-Med, Bryon continued to obtain an MS in Reproductive Physiology from the University of New Hampshire. He joined Avacta Life Sciences from Cell Signaling Technology (CST), a market leader in antibody development, production, and research. Initially a Product Scientist developing and validating a wide variety of antibodies and applications, Bryon moved to CST’s newly formed European subsidiary, taking on the role of European Business Development Executive. Here Bryon was responsible for market development, technology scouting, key pharma account management, and growing the proteomic kit and services business. Bryon’s experience gives him a insight and practical application of many techniques and technologies utilised throughout the industry.